Sunday, January 19, 2025

CATEGORY

Health Economics

Managed Entry Agreements Open Doors for Expensive New Drugs in Major Markets

High-priced medications targeting severe and previously untreatable conditions are gaining approval across South Korea, England, Australia, and Canada. These approvals come despite limited initial...

HHS Targets 15 Costly Drugs for Medicare Price Cuts

The U.S. Department of Health and Human Services (HHS) has expanded its efforts to make prescription medications more affordable for seniors. By selecting 15...

Global Health Bodies Introduce New Guidelines for Drug Assessment

NICE, alongside international health technology assessment agencies, has unveiled a comprehensive report to enhance the use of surrogate endpoints in health economic evaluations. This...

Clinical Pharmacy Programs Save Egypt Hospitals $8.6 Million Over Six Years

Egyptian tertiary hospitals have successfully implemented clinical pharmacy interventions, resulting in significant cost savings and enhanced patient care over a six-year period.Clinical pharmacy services...

ERCP Procedure Infections Cost Italy Millions Annually

Infections linked to ERCP procedures are burdening Italy's healthcare system with significant financial implications. A recent study highlights the economic strain caused by multidrug-resistant...

HHS Selects 15 New Drugs to Slash Medicare Costs for Seniors

The U.S. Department of Health and Human Services (HHS) has expanded its initiative to reduce prescription drug expenses for seniors by selecting 15 additional...

Pharmac Expands Access to Key Medicines for Blood Cancer and Inflammatory Conditions

Pharmac is soliciting public input on its proposal to broaden the availability of three critical medications starting May 1, 2025. This initiative aims to...

New Study Highlights Value Attributes of Advanced Therapy Medicinal Products

Advanced therapy medicinal products (ATMPs) are gaining attention for their potential to revolutionize healthcare. A recent study delves into understanding what stakeholders value most...

Remote Monitoring Saves Costs in Chronic Depression Treatment

Innovative remote monitoring technologies are proving to be a financially viable option for managing chronic depression, according to recent research. This advancement leverages mobile...

Managed Entry Agreements Facilitate Access to Expensive Drugs in Four Nations

Health systems in South Korea, England, Australia, and Canada are increasingly approving high-priced medications through innovative financial arrangements, despite limited initial evidence. This trend...

Global Health Agencies Approve Costly Medications via Innovative Agreements

Health authorities in South Korea, England, Australia, and Canada are opening doors for high-priced drugs by adopting flexible appraisal methods. These nations are prioritizing...

Reusable Tools Outperform Disposable Alternatives in Endoscopic Surgeries

A recent comprehensive review highlights the superior environmental and economic benefits of reusable and reprocessed disposable instruments over new disposables in endoscopic surgery. The...

German Study Reveals Varied Costs and Treatment Adherence for Psoriasis Medications

A comprehensive analysis of German statutory health insurance data from 2014 to 2019 uncovers significant insights into the prevalence, treatment patterns, and economic burden...

Reusable Surgical Instruments Prove Superior in Endoscopic Procedures

A comprehensive review highlights the advantages of using reusable and reprocessed disposable instruments over their new disposable counterparts in endoscopic surgery. The study meticulously...

Researchers Highlight Inconsistencies in Telehealth Economic Studies

Telehealth's expanding role in modern healthcare systems necessitates robust economic evaluations to ensure its sustainable integration and effectiveness. Economic Evaluations Fall Short of Standard Guidelines...

Latest news